ONCY
insider transactionsONCOLYTICS BIOTECH INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Chief Operating Officer
$0
145.0K sh
Own New
-
Grant·A
Kirk Look KEY
Chief Financial Officer
$0
260.0K sh
Own New
-
Grant·A
Jared Kelly KEY
Chief Executive Officer
$0
755.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Chief Medical Officer
$0
260.0K sh
Own New
-
Grant·A
Chief Technology Officer
$0
260.0K sh
Own New
-
Grant·A
Director
$0
96.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Chief Business Officer
$0
260.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
270.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | Jonathan Rigby | Grant A | 30.0K | $0 |
| Jun 1, 2026 | Wayne Pisano | Grant A | 30.0K | $0 |
| Jun 1, 2026 | James T. Parsons | Grant A | 30.0K | $0 |
| Jun 1, 2026 | Bernd R. Seizinger | Grant A | 30.0K | $0 |
| Jun 1, 2026 | John Bearden Mcadory | Grant A | 145.0K | $0 |
| Jun 1, 2026 | Kirk Look KEY | Grant A | 260.0K | $0 |
| Jun 1, 2026 | Jared Kelly KEY | Grant A | 755.0K | $0 |
| Jun 1, 2026 | Angela Holtham | Grant A | 30.0K | $0 |
| Jun 1, 2026 | Thomas Charles Heineman | Grant A | 260.0K | $0 |
| Jun 1, 2026 | Allison Hagerman | Grant A | 260.0K | $0 |
| Jun 1, 2026 | Stephen C. Glover | Grant A | 96.0K | $0 |
| Jun 1, 2026 | Deborah Margaret Brown | Grant A | 30.0K | $0 |
| Jun 1, 2026 | Andrew Aromando | Grant A | 260.0K | $0 |
| Jun 1, 2026 | Patricia S Andrews | Grant A | 30.0K | $0 |
| Mar 25, 2026 | Patricia S Andrews | Grant A | 270.0K | $0 |
About ONCY insider trading
This page tracks insider transactions for ONCOLYTICS BIOTECH INC (ONCY) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.